National Center for Injury Prevention and Control Initial Review Group (NCIPC/IRG), 19522 [E7-7339]

Download as PDF 19522 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices Dated: April 10, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7331 Filed 4–13–07; 10:39 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 7),’’ Request for Application Number (RFA) DP07–002 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 12 p.m.–4 p.m., June 5, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of research grant applications received in response to RFA DP07–002, ‘‘Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 7).’’ Contact Person for More Information: Sheree Marshall Williams, PhD, M.Sc., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, telephone 404.639.4896. pwalker on PROD1PC71 with NOTICES The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2007. Elaine L. Baker Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7332 Filed 4–17–07; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 17:04 Apr 17, 2007 Jkt 211001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group (NCIPC/IRG) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meetings of the aforementioned committee: Times and Dates: 2 p.m.–5 p.m., May 14, 2007 (Closed). 2 p.m.–5 p.m., May 15, 2007 (Closed). 2 p.m.–5 p.m., May 16, 2007 (Closed). 2 p.m.–5 p.m., May 17, 2007 (Closed). 2 p.m.–5 p.m., May 18, 2007 (Closed). Place: The conference calls will originate at the Centers for Disease Control and Prevention, Vanderbilt Building, Koger Center, Atlanta, Georgia. Times and Dates: 9 a.m.–10 a.m., May 21, 2007 (Open). 10 a.m.–5 p.m., May 21, 2007 (Closed). 9 a.m.–3 p.m., May 22, 2007 (Closed). 3 p.m.–5 p.m., May 22, 2007 (Open). 5 p.m.–7 p.m., May 22, 2007 (Closed). 9 a.m.–5:30 p.m., May 23, 2007 (Closed). 9 a.m.–5 p.m., May 24, 2007 (Closed). Place: Sheraton Midtown Atlanta Hotel Colony Square, Atlanta, Georgia. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of individual research grant and cooperative agreement applications submitted in response to two Fiscal Year 2007 Requests for Applications related to the following individual research announcements: 07002, Family and Dyadic Focused Interventions to PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Prevent Intimate Partner Violence; 07003, Maximizing Protective Factors for Youth Violence; 07004, Abusive Head Trauma (AHT) Prevention; 07005, Understanding Bullying and Sexual Violence Perpetration and Factors Associated with Both Outcomes; 07006, Grants for Traumatic Injury Biomechanics Research; 07007, Dissemination Research on Fall Prevention: ‘‘Stepping On’’ in a U.S. Community Setting; and 07008, The Impact of Traumatic Brain Injury Among Incarcerated Persons. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Jane Suen, PhD, NCIPC/IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone 770/ 488–1240. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 10, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7339 Filed 4–17–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1080, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 72 FR 14578, dated March 28, 2007) is amended to reflect the reorganization of the Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the mission statements for the Coordinating Center for Infectious Diseases (CV) and the Office of the Director (CVA), and insert the following: E:\FR\FM\18APN1.SGM 18APN1

Agencies

[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Page 19522]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7339]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Injury Prevention and Control Initial Review 
Group (NCIPC/IRG)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meetings of the aforementioned 
committee:

    Times and Dates:
    2 p.m.-5 p.m., May 14, 2007 (Closed).
    2 p.m.-5 p.m., May 15, 2007 (Closed).
    2 p.m.-5 p.m., May 16, 2007 (Closed).
    2 p.m.-5 p.m., May 17, 2007 (Closed).
    2 p.m.-5 p.m., May 18, 2007 (Closed).
    Place: The conference calls will originate at the Centers for 
Disease Control and Prevention, Vanderbilt Building, Koger Center, 
Atlanta, Georgia.

    Times and Dates:
    9 a.m.-10 a.m., May 21, 2007 (Open).
    10 a.m.-5 p.m., May 21, 2007 (Closed).
    9 a.m.-3 p.m., May 22, 2007 (Closed).
    3 p.m.-5 p.m., May 22, 2007 (Open).
    5 p.m.-7 p.m., May 22, 2007 (Closed).
    9 a.m.-5:30 p.m., May 23, 2007 (Closed).
    9 a.m.-5 p.m., May 24, 2007 (Closed).
    Place: Sheraton Midtown Atlanta Hotel Colony Square, Atlanta, 
Georgia.

    Status: Portions of the meetings will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5, U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Section 10(d) of Public 
Law 92-463.
    Purpose: This group is charged with providing advice and guidance 
to the Secretary, Department of Health and Human Services, and the 
Director, CDC, concerning the scientific and technical merit of grant 
and cooperative agreement applications received from academic 
institutions and other public and private profit and nonprofit 
organizations, including State and local government agencies, to 
conduct specific injury research that focuses on prevention and 
control.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of individual research grant and cooperative 
agreement applications submitted in response to two Fiscal Year 2007 
Requests for Applications related to the following individual research 
announcements: 07002, Family and Dyadic Focused Interventions to 
Prevent Intimate Partner Violence; 07003, Maximizing Protective Factors 
for Youth Violence; 07004, Abusive Head Trauma (AHT) Prevention; 07005, 
Understanding Bullying and Sexual Violence Perpetration and Factors 
Associated with Both Outcomes; 07006, Grants for Traumatic Injury 
Biomechanics Research; 07007, Dissemination Research on Fall 
Prevention: ``Stepping On'' in a U.S. Community Setting; and 07008, The 
Impact of Traumatic Brain Injury Among Incarcerated Persons.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Jane Suen, PhD, NCIPC/IRG, 
CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341-3724, 
telephone 770/488-1240.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-7339 Filed 4-17-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.